Medicare Enrolled
Dr. Asker Asmi, M.D.
Critical Care Medicine · Riverview, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Asmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Asmi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Asmi
Dr. Asker Asmi is a critical care medicine specialist in Riverview, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Asmi performed 2,883 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Asmi received a total of $10,703 from 47 pharmaceutical and/or device companies across 580 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Asmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 5% volume in MI
$10,703 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,883
Medicare services
Top 5% in MI for critical care medicine
Not available
Unique patients (not deduplicated)
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
828 | $97 | $313 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
241 | $39 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
211 | $132 | $356 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
188 | $43 | $90 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
181 | $175 | $450 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
142 | $47 | $123 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
119 | $49 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
110 | $65 | $218 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
103 | $20 | $75 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
103 | $33 | $66 |
| New patient office visit, complex (60-74 min) | 89 | $163 | $418 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
88 | $30 | $110 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
84 | $39 | $95 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
81 | $26 | $104 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
81 | $36 | $77 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $124 | $331 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
53 | $477 | $1,093 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
51 | $491 | $1,170 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
41 | $65 | $256 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
24 | $97 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,703
Total received (2018-2024)
Avg $1,529/year across 7 years
Top 16% in MI for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
580
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,457
2023
$2,024
2022
$2,223
2021
$1,639
2020
$749
2019
$1,128
2018
$1,482
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$215
Boehringer Ingelheim Pharmaceuticals, Inc.
$207
Mylan Specialty L.P.
$158
ANI Pharmaceuticals, Inc.
$133
Regeneron Healthcare Solutions, Inc.
$111
GlaxoSmithKline, LLC.
$106
Grifols USA, LLC
$100
JAZZ PHARMACEUTICALS INC.
$65
Avadel CNS Pharmaceuticals, LLC
$56
Takeda Pharmaceuticals U.S.A., Inc.
$56
Baxter Healthcare
$53
Actelion Pharmaceuticals US, Inc.
$44
GENZYME CORPORATION
$31
Axsome Therapeutics, Inc.
$26
United Therapeutics Corporation
$23
Azurity Pharmaceuticals, Inc.
$20
IDORSIA PHARMACEUTICALS US INC
$20
ZOLL Respicardia, Inc.
$18
Inspire Medical Systems, Inc.
$15
Top 3 companies account for 39.7% of 2024 payments
All-time payments by company (2018-2024) ›
Mylan Specialty L.P.
$1,571
AstraZeneca Pharmaceuticals LP
$1,443
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,382
GlaxoSmithKline, LLC.
$1,239
Sunovion Pharmaceuticals Inc.
$641
Grifols USA, LLC
$568
Baxter Healthcare
$353
Regeneron Healthcare Solutions, Inc.
$340
Takeda Pharmaceuticals U.S.A., Inc.
$334
GENZYME CORPORATION
$301
United Therapeutics Corporation
$237
Inogen, Inc.
$165
Actelion Pharmaceuticals US, Inc.
$157
Electromed, Inc.
$134
ANI Pharmaceuticals, Inc.
$133
Harmony Biosciences LLC
$131
Insmed, Inc.
$118
Philips Electronics North America Corporation
$102
Genentech USA, Inc.
$100
Avadel CNS Pharmaceuticals, LLC
$100
JAZZ PHARMACEUTICALS INC.
$99
Advanced Respiratory, Inc
$92
SANOFI-AVENTIS U.S. LLC
$77
Mallinckrodt Hospital Products Inc.
$74
Janssen Pharmaceuticals, Inc
$73
Circassia Pharmaceuticals Inc
$70
BOSTON SCIENTIFIC CORPORATION
$70
Axsome Therapeutics, Inc.
$55
Inspire Medical Systems, Inc.
$48
Shire North American Group Inc
$43
Teva Pharmaceuticals USA, Inc.
$40
Pulmonx Corporation
$39
Gilead Sciences, Inc.
$36
ADVANCED RESPIRATORY, INC
$33
PORTOLA PHARMACEUTICALS, INC.
$33
Mallinckrodt Enterprises LLC
$31
Resmed Corp
$28
ABBVIE INC.
$27
Merck Sharp & Dohme Corporation
$25
Vapotherm Inc
$25
Merck Sharp & Dohme LLC
$24
Azurity Pharmaceuticals, Inc.
$20
IDORSIA PHARMACEUTICALS US INC
$20
Jazz Pharmaceuticals Inc.
$19
ZOLL Respicardia, Inc.
$18
Cumberland Pharmaceuticals, Inc.
$18
PFIZER INC.
$16
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · AirDuo Digihaler · AirSense · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BROVANA · CHARTIS CATHETER · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Esbriet · FARXIGA · FASENRA · GLASSIA · HORIZANT · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · LONHALA MAGNAIR · LUMRYZ · NUCALA · OFEV · OPSUMIT · PAXLOVID · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · Respiratoriy Care Undiv · SEEBRI · SEEBRI NEOHALER · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · Vibativ · WAKIX · WATCHMAN · Wakix · XARELTO · XYWAV · Xyrem · YUPELRI · Yupelri · ZERBAXA · inCourage · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Critical care medicines in nearby ZIP areas
73
County median income
$59,521
Nearest hospital to ZIP centroid (approximate)
COREWELL HEALTH TRENTON HOSPITAL
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Asmi is a clinical cardiology specialist, with above-average Medicare volume (top 5% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Asmi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Asmi performed 828 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Asmi receive payments from pharmaceutical companies?
Yes. Dr. Asmi received a total of $10,703 from 47 companies across 580 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Asmi's costs compare to other critical care medicines in Riverview?
Dr. Asmi's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Asmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Riverview
Browse critical care medicines in Riverview ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in MI
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in MI
Which MI critical care medicines receive the most from drug and device companies.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology